MWAC
TEVA icon

Mariner Wealth Advisors (Cincinnati)’s Teva Pharmaceuticals TEVA Stock Holding History

Mariner Wealth Advisors (Cincinnati)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-15,836
Closed -$526K – 281
2017
Q2 		$526K Buy
15,836
+1,325
+9% +$41K 0.04% 162
2017
Q1 		$466K Buy
14,511
+2,305
+19% +$78.7K 0.03% 170
2016
Q4 		$442K Buy
12,206
+1,001
+9% +$40K 0.03% 173
2016
Q3 		$516K Sell
11,205
-1,094
-9% -$57.1K 0.04% 159
2016
Q2 		$618K Buy
12,299
+1,180
+11% +$62.8K 0.06% 143
2016
Q1 		$595K Sell
11,119
-601
-5% -$35.3K 0.06% 137
2015
Q4 		$769K Buy
+11,720
New +$724K 0.08% 122
2015
Q1 		$749K Buy
12,025
+146
+1% +$8.49K 0.11% 86
2014
Q4 		$683K Buy
11,879
+294
+3% +$16.4K 0.1% 91
2014
Q3 		$623K Buy
11,585
+1,385
+14% +$73.4K 0.1% 85
2014
Q2 		$535K Buy
10,200
+840
+9% +$42.9K 0.08% 92
2014
Q1 		$495K Buy
9,360
+780
+9% +$36K 0.08% 91
2013
Q4 		$344K Buy
+8,580
New +$338K 0.06% 110

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Mariner Wealth Advisors (Cincinnati)'s TEVA Position: Q3 2017 in Review

Mariner Wealth Advisors (Cincinnati) sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 15,836 shares — an estimated $526K sold.

Mariner Wealth Advisors (Cincinnati) first reported a position in TEVA in Q4 2013 and held it in 13 quarters. The position peaked at $769K in Q4 2015. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Mariner Wealth Advisors (Cincinnati) reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Mariner Wealth Advisors (Cincinnati) sold 15,836 Teva Pharmaceuticals shares in Q3 2017, an estimated $526K.
  • Mariner Wealth Advisors (Cincinnati) first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 13 quarters.
  • Mariner Wealth Advisors (Cincinnati)'s Teva Pharmaceuticals position peaked at $769K in Q4 2015.
  • 535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Mariner Wealth Advisors (Cincinnati)'s 13F filing for Q3 2017, filed 13 Nov 2017.